HBsAg vaccine (Chengdu Institute)

N/A

Report date: 2025/03/20 15:46:29

Base Information

Drug NameHBsAg vaccine (Chengdu Institute)
Drug Alias Namerecombinant hepatitis B surface antigen vaccine (Chengdu Institute)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionHBsAg inhibitors
TargetsHepatitis B Surface Antigens
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A